טוען...
Post-ischemic azotemia as a partial ‘brake’, slowing progressive kidney disease
BACKGROUND: Recent experimental work suggests a paradox: although uremia evokes systemic toxicities, in the setting of AKI, it can induce intrarenal cytoprotective and anti-inflammatory effects. Whether these influences can attenuate post-ischemic kidney disease progression remains unknown. METHODS:...
שמור ב:
Main Authors: | , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Oxford University Press
2013
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3685309/ https://ncbi.nlm.nih.gov/pubmed/23543590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gft040 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|